Cargando…
Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion
Breastfeeding is key for infant development and growth. Breast milk contains different bioactive compounds including antibodies. Recent studies have demonstrated the presence of breast milk SARS-CoV-2 antibodies after maternal infection and vaccination. However, the potential impact on the infant ha...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147794/ https://www.ncbi.nlm.nih.gov/pubmed/35631258 http://dx.doi.org/10.3390/nu14102117 |
_version_ | 1784716894840815616 |
---|---|
author | Calvo-Lerma, Joaquim Bueno-Llamoga, Pierre Bäuerl, Christine Cortés-Macias, Erika Selma-Royo, Marta Pérez-Cano, Francisco Lerin, Carles Martínez-Costa, Cecilia Collado, Maria Carmen |
author_facet | Calvo-Lerma, Joaquim Bueno-Llamoga, Pierre Bäuerl, Christine Cortés-Macias, Erika Selma-Royo, Marta Pérez-Cano, Francisco Lerin, Carles Martínez-Costa, Cecilia Collado, Maria Carmen |
author_sort | Calvo-Lerma, Joaquim |
collection | PubMed |
description | Breastfeeding is key for infant development and growth. Breast milk contains different bioactive compounds including antibodies. Recent studies have demonstrated the presence of breast milk SARS-CoV-2 antibodies after maternal infection and vaccination. However, the potential impact on the infant has not been explored yet. As a first step, we aimed at assessing the potential persistence of SARS-CoV-2 IgA and IgG antibodies from infected and vaccinated women in the gastrointestinal tract of the infants by means of an in vitro-simulated gastrointestinal digestion approach. Breast milk samples from 10 lactating women receiving mRNA vaccination against SARS-CoV-2 (n = 5 with BNT162b2 mRNA and n = 5 with mRNA-1273) and also, COVID-19 infected (n = 5) were included. A control group with women with no exposure to the virus (n = 10 pre-pandemic) were also studied. The presence of IgA and IgG SARS-CoV-2 antibody levels was determined by ELISA after the gastric and intestinal stages. The impact of digested antibodies on infant gut microbiota was tested by simulating colonic fermentation with two different fecal inoculums: infants from vaccinated and non-vaccinated mothers. Specific gut microbial groups were tested by targeted qPCR. In vitro infant gastrointestinal digestion significantly decreased the levels of both anti-SARS-CoV-2 IgA and IgG. However, both remained resistant in all the study groups except in that evaluating breast milk samples from infected women, in which IgG was degraded below the cut-off values in the intestinal phase. No effect of the antibodies on microbiota were identified after digestion. In conclusion, antibody levels against SARS-CoV-2 are reduced after in vitro-simulated gastrointestinal tract but remain present, so a positive biological effect could be expected from this infant immunization pathway. |
format | Online Article Text |
id | pubmed-9147794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91477942022-05-29 Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion Calvo-Lerma, Joaquim Bueno-Llamoga, Pierre Bäuerl, Christine Cortés-Macias, Erika Selma-Royo, Marta Pérez-Cano, Francisco Lerin, Carles Martínez-Costa, Cecilia Collado, Maria Carmen Nutrients Article Breastfeeding is key for infant development and growth. Breast milk contains different bioactive compounds including antibodies. Recent studies have demonstrated the presence of breast milk SARS-CoV-2 antibodies after maternal infection and vaccination. However, the potential impact on the infant has not been explored yet. As a first step, we aimed at assessing the potential persistence of SARS-CoV-2 IgA and IgG antibodies from infected and vaccinated women in the gastrointestinal tract of the infants by means of an in vitro-simulated gastrointestinal digestion approach. Breast milk samples from 10 lactating women receiving mRNA vaccination against SARS-CoV-2 (n = 5 with BNT162b2 mRNA and n = 5 with mRNA-1273) and also, COVID-19 infected (n = 5) were included. A control group with women with no exposure to the virus (n = 10 pre-pandemic) were also studied. The presence of IgA and IgG SARS-CoV-2 antibody levels was determined by ELISA after the gastric and intestinal stages. The impact of digested antibodies on infant gut microbiota was tested by simulating colonic fermentation with two different fecal inoculums: infants from vaccinated and non-vaccinated mothers. Specific gut microbial groups were tested by targeted qPCR. In vitro infant gastrointestinal digestion significantly decreased the levels of both anti-SARS-CoV-2 IgA and IgG. However, both remained resistant in all the study groups except in that evaluating breast milk samples from infected women, in which IgG was degraded below the cut-off values in the intestinal phase. No effect of the antibodies on microbiota were identified after digestion. In conclusion, antibody levels against SARS-CoV-2 are reduced after in vitro-simulated gastrointestinal tract but remain present, so a positive biological effect could be expected from this infant immunization pathway. MDPI 2022-05-19 /pmc/articles/PMC9147794/ /pubmed/35631258 http://dx.doi.org/10.3390/nu14102117 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Calvo-Lerma, Joaquim Bueno-Llamoga, Pierre Bäuerl, Christine Cortés-Macias, Erika Selma-Royo, Marta Pérez-Cano, Francisco Lerin, Carles Martínez-Costa, Cecilia Collado, Maria Carmen Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title | Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title_full | Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title_fullStr | Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title_full_unstemmed | Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title_short | Persistence of Anti SARS-CoV-2 Antibodies in Breast Milk from Infected and Vaccinated Women after In Vitro-Simulated Gastrointestinal Digestion |
title_sort | persistence of anti sars-cov-2 antibodies in breast milk from infected and vaccinated women after in vitro-simulated gastrointestinal digestion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147794/ https://www.ncbi.nlm.nih.gov/pubmed/35631258 http://dx.doi.org/10.3390/nu14102117 |
work_keys_str_mv | AT calvolermajoaquim persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT buenollamogapierre persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT bauerlchristine persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT cortesmaciaserika persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT selmaroyomarta persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT perezcanofrancisco persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT lerincarles persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT martinezcostacecilia persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion AT colladomariacarmen persistenceofantisarscov2antibodiesinbreastmilkfrominfectedandvaccinatedwomenafterinvitrosimulatedgastrointestinaldigestion |